| Name | Title | Contact Details |
|---|---|---|
Seth Harmon |
Senior Vice President Finance and | Profile |
GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its late-stage product candidate, voxelotor (previously called GBT440), for the treatment of sickle cell disease.
Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway.
Elco Laboratories Inc is a University Park, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Walter Payton Cancer Fund is a Schaumburg, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MultiPlan is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.